BROEN-LAB A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.7% 0.4% 0.4% 0.4% 0.4%  
Credit score (0-100)  96 100 100 100 100  
Credit rating  AA AAA AAA AAA AAA  
Credit limit (kDKK)  8,303.6 9,630.6 11,406.3 15,638.8 16,473.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  48,551 58,203 77,027 96,983 93,430  
EBITDA  1,937 6,270 7,789 32,270 36,769  
EBIT  1,937 6,270 7,789 32,270 36,769  
Pre-tax profit (PTP)  13.2 4,535.4 7,362.4 33,083.5 36,677.1  
Net earnings  -25.1 3,225.0 5,823.2 26,011.9 28,575.5  
Pre-tax profit without non-rec. items  13.2 4,535 7,362 33,083 36,677  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  19,973 18,320 16,235 15,871 15,325  
Shareholders equity total  76,813 79,837 85,547 111,280 117,433  
Interest-bearing liabilities  35,504 19,844 23,674 2,988 2,704  
Balance sheet total (assets)  145,060 139,242 155,056 157,338 152,087  

Net Debt  34,680 16,501 5,808 -19,932 -21,825  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  48,551 58,203 77,027 96,983 93,430  
Gross profit growth  7.0% 19.9% 32.3% 25.9% -3.7%  
Employees  68 0 0 66 69  
Employee growth %  0.0% -100.0% 0.0% 0.0% 4.5%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  145,060 139,242 155,056 157,338 152,087  
Balance sheet change%  -12.2% -4.0% 11.4% 1.5% -3.3%  
Added value  1,937.3 6,270.5 7,789.1 32,270.3 36,769.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -5,221 -9,711 -17,451 1,666 -6,753  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  4.0% 10.8% 10.1% 33.3% 39.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  1.5% 4.9% 5.9% 22.4% 24.4%  
ROI %  1.8% 6.1% 7.5% 27.5% 28.1%  
ROE %  -0.0% 4.1% 7.0% 26.4% 25.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  53.0% 57.6% 55.4% 70.9% 77.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  1,790.2% 263.1% 74.6% -61.8% -59.4%  
Gearing %  46.2% 24.9% 27.7% 2.7% 2.3%  
Net interest  0 0 0 0 0  
Financing costs %  5.1% 8.9% 6.0% 14.1% 40.2%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.4 0.5 1.1 1.6 2.7  
Current Ratio  0.7 0.9 1.6 2.3 4.1  
Cash and cash equivalent  824.3 3,343.7 17,866.1 22,919.9 24,529.4  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -14,049.2 -5,623.2 20,617.3 38,803.6 52,318.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  28 0 0 489 533  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  28 0 0 489 533  
EBIT / employee  28 0 0 489 533  
Net earnings / employee  -0 0 0 394 414